Following the decision taken to part-review and part-reissue NICE Technology Appraisal Guidance No.349 Dexamethasone intravitreal implant for treating diabetic macular oedema, I am writing to inform you of the draft timelines that we have planned for your information.
The appraisal is expected to start during September 2021 with a consultation on the draft scope. It is then anticipated that the final scope will be released along with an invitation to participate in the appraisal during October 2021. The deadline for submissions is expected in approximately early January 2022.